封面
市场调查报告书
商品编码
1642119

医药物流-市场占有率分析、产业趋势与统计、成长预测(2025-2030 年)

Pharmaceutical Logistics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

出版日期: | 出版商: Mordor Intelligence | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2025 年医药物流市场规模预计为 5,608.1 亿美元,预计到 2030 年将达到 7,340 亿美元,预测期内(2025-2030 年)的复合年增长率为 5.53%。

医药物流-市场-IMG1

关键亮点

  • 製药商越来越多地将包装和标籤服务外包给第三方供应商。许多公司正在向以前未开发的地区扩张,例如撒哈拉以南非洲和南美洲。然而,这些公司强调与拥有强大製药专业知识的本地物流供应商合作的重要性。儘管有这些好处,人们也担心外包可能导致服务品质下降和失控。
  • 预计未来几年海运和空运医药物流的需求将推动产业成长。特别是海运,可以降低高达 80% 的成本并减少对人员的需求,同时最大限度地减少包装、储存和碳足迹。航空货运物流越来越多地用于贵重疫苗和药品的远距和洲际配送,进一步促进了该行业的扩张。对非处方药(OTC)的需求也在增加,例如维生素、矿物质和补充剂(VMS)、感冒咳嗽药、胃肠药和皮肤病治疗药。
  • 此外,医疗保健领域对快速援助的需求日益增加,从而推动了医药物流市场的发展。建立单一来源分销管道被视为降低分销成本、提高医药物流效率的一种方式。

医学流市场趋势

低温运输物流需求不断增加

  • 预计未来几年低温运输物流领域将大幅成长。这项扩张的关键驱动因素是对疫苗等常温产品的需求不断增长,这些产品需要精确的温度控制物流,以确保产品在分销过程中的功效。
  • 政府法规要求对温度敏感的药物保持精确的温度,预计也将有助于该领域的成长。远端资讯处理在低温运输医药物流中的应用正在增加,使企业能够提高货物运输的效率、连结性和安全性。生技药品和医疗产品的製造和分销需要温控环境,使得製药公司越来越依赖温控运输和冷藏系统。
  • 供应链管理和整合技术的最新进展促进了用于运输温度敏感货物的有效低温运输物流的无缝整合。这在发展供应链业务的同时确保了药品的品质和安全。整体来看,专业化的低温运输物流企业正推动温控物流业的发展,为产业带来良好的发展前景。

亚太地区可望创下最高成长

  • 预计未来几年亚太地区将实现最高成长率,这主要归因于对药品的需求激增和对医疗保健基础设施的大量投资。例如在印度新德里,印度政府公布的「药品生产挂钩激励计画」预计将在2023年9月带来2,581.3亿印度卢比的投资,并创造5,6171个新的就业机会。
  • 亚太地区是全球最大、成长最快的医药市场之一,其中包括中国、印度、日本和韩国。这些国家对医疗服务和药品的需求不断增长,推动对高效物流解决方案的需求,以确保及时交付。
  • 对机场、海港和公路网路等交通基础设施的投资正在提高整个全部区域的物流能力。现代化努力旨在简化药品流动,减少运输时间并提高供应链效率。

医药物流产业概况

市场高度细分,全球各地有许多公司。该行业的主要企业包括 DHL、DB Group 和 FedEx。为了维持市场地位,医药物流公司不断采取併购等策略性措施。此外,这些公司也投资远端资讯处理、遥感探测和监控、GPS和GIS整合等技术来运输货物,为客户提供安全、便利的医药物流服务。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第 1 章 简介

  • 调查的主要发现
  • 调查前提
  • 研究范围

第二章调查方法

  • 分析方法
  • 研究阶段

第 3 章市场考量与动态

  • 当前市场状况
  • 政府措施和监管方面
  • 产业技术趋势
  • 市场动态
    • 市场驱动因素
      • 网路药局推动成长
      • 非处方药需求增加
    • 市场限制
      • 物流成本高
      • 严格的政府法规
    • 市场机会
      • 增加对药物配送无人机技术的投资
  • 产业吸引力-波特五力分析
    • 供应商的议价能力
    • 消费者/购买者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争强度
  • 价值链/供应链分析
  • COVID-19 市场影响

第 4 章 市场细分

  • 按产品
    • 学名药
    • 品牌药物
  • 按运输方式
    • 低温运输运输
    • 非低温运输运输
  • 按应用
    • 生物製药
    • 化学品和製药
    • 专科药物
  • 交通方式
    • 空运
    • 铁路运输
    • 道路运输
    • 海上运输
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 义大利
      • 欧洲其他地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 其他拉丁美洲国家
    • 其他的

第五章 竞争格局

  • 公司简介
    • Deutsche Post DHL
    • Kuehne+Nagel
    • UPS(Marken)
    • DB Group
    • FedEx
    • Nippon Express
    • World Courier
    • SF Express
    • CEVA Logistics
    • Agility
    • DSV
    • Kerry Logistics
    • CH Robinson
    • Air Canada Cargo
    • Lineage Logistics
    • United States Cold Storage
    • Americold Logistics LLC
    • Nichirei Logistics Group Inc.
    • Kloosterboer
    • NewCold Advanced Cold Logistics
    • VersaCold Logistics Services
    • Cloverleaf Cold Storage Co.*
  • 其他公司

第六章:市场的未来

第七章 附录

第八章 免责声明

简介目录
Product Code: 66686

The Pharmaceutical Logistics Market size is estimated at USD 560.81 billion in 2025, and is expected to reach USD 734.00 billion by 2030, at a CAGR of 5.53% during the forecast period (2025-2030).

Pharmaceutical Logistics - Market - IMG1

Key Highlights

  • Pharmaceutical manufacturing companies are increasingly turning to third-party providers for packaging and labeling services. Many of these companies are expanding their operations into previously untapped regions like Sub-Saharan Africa and South America. However, they emphasize the importance of partnering with local logistics providers who possess strong expertise in pharmaceuticals. Despite the benefits, there are concerns about potential service quality deterioration and loss of control associated with outsourcing.
  • The demand for sea and air freight pharmaceutical logistics is expected to drive industry growth in the coming years. Sea freight, in particular, offers cost savings of up to 80% and reduces staffing needs while also minimizing packaging, storage, and carbon footprint. Air freight logistics are increasingly used for long-distance and intercontinental distribution of valuable vaccines and medicines, further contributing to industry expansion. The market is also witnessing increased demand for over-the-counter (OTC) medications such as vitamins, minerals, supplements (VMS), common cold and cough remedies, gastrointestinal drugs, and dermatology treatments.
  • Furthermore, there is a growing need for fast-track assistance in the healthcare sector, which is boosting the pharmaceutical logistics market. The establishment of a single-source distribution channel is seen as a way to reduce distribution costs and enhance efficiency in pharmaceutical logistics.

Pharmaceutical Logistics Market Trends

Increasing Demand for Cold Chain Logistics in the Sector

  • The cold chain logistics sector is poised for significant growth in the coming years. This expansion is primarily driven by increasing demand for ambient products, such as vaccines, necessitating precise temperature-controlled logistics to ensure product efficacy during distribution.
  • Government regulations mandating accurate temperature maintenance for highly temperature-sensitive pharmaceuticals are also expected to contribute to the segment's growth. The adoption of telematics in cold-chain pharmaceutical logistics is on the rise, enabling companies to improve efficiency, connectivity, and safety in cargo transportation. Given the requirement for temperature-controlled environments in the manufacturing and distribution of biological and medical products, pharmaceutical companies are increasingly relying on temperature-controlled transportation and cold storage systems.
  • Recent advancements in supply chain management and integration technologies have facilitated the seamless integration of effective cold-chain logistics for transporting temperature-sensitive goods. This has led to the growth of supply chain businesses while ensuring the quality and safety of pharmaceutical products. Overall, the provision of cold chain logistics by specialized firms is driving growth in the temperature-controlled logistics sector, promising a bright future for the industry.

Asia-Pacific is Poised to Witness the Highest Growth Rate

  • Asia-Pacific is poised to witness the highest growth rate in the future, primarily driven by a surge in demand for pharmaceutical products and substantial investments in healthcare infrastructure. For example, New Delhi, India, witnessed investments of INR 25,813 crore and the addition of 56,171 new jobs as of September 2023 under the production-linked incentive scheme for pharmaceuticals, as announced by the government of India.
  • Asia-Pacific is home to some of the world's largest and fastest-growing pharmaceutical markets, including China, India, Japan, and South Korea. The increasing demand for healthcare services and pharmaceutical products in these countries drives the need for efficient logistics solutions to ensure timely delivery.
  • Investments in transportation infrastructure, such as airports, seaports, and road networks, are improving logistics capabilities across the region. Modernization efforts aim to streamline the movement of pharmaceutical goods, reducing transit times and enhancing supply chain efficiency.

Pharmaceutical Logistics Industry Overview

The market is highly fragmented, with the presence of many companies across the globe. Some of the top names in this industry include DHL, DB Group, and FedEx. To maintain their position in the market, pharmaceutical logistics companies are continuously undertaking strategic initiatives such as mergers and acquisitions. Furthermore, players are investing in technologies such as telematics, remote sensing and monitoring, and GPS and GIS integration in transporting cargo, thereby providing customers with safe and convenient pharmaceutical logistics services.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Key Deliverables of the Study
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

  • 2.1 Analysis Methodology
  • 2.2 Research Phases

3 MARKET INSIGHTS AND DYNAMICS

  • 3.1 Current Market Scenario
  • 3.2 Government Initiatives and Regulatory Aspects
  • 3.3 Technological Trends in the Industry
  • 3.4 Market Dynamics
    • 3.4.1 Market Drivers
      • 3.4.1.1 Online Pharmacies to Facilitate Growth
      • 3.4.1.2 Increasing Demand for Over-the-counter (OTC) Medicines
    • 3.4.2 Market Restraints
      • 3.4.2.1 High Cost of Logistics
      • 3.4.2.2 Stringent Government Regulations
    • 3.4.3 Market Opportunities
      • 3.4.3.1 Increasing Investments in Drone Technology for Medication Delivery
  • 3.5 Industry Attractiveness - Porter's Five Forces Analysis
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Consumers/Buyers
    • 3.5.3 Threat of New Entrants
    • 3.5.4 Threat of Substitute Products
    • 3.5.5 Intensity of Competitive Rivalry
  • 3.6 Value Chain/Supply Chain Analysis
  • 3.7 Impact of COVID-19 on the Market

4 MARKET SEGMENTATION

  • 4.1 By Product
    • 4.1.1 Generic Drugs
    • 4.1.2 Branded Drugs
  • 4.2 By Mode of Operation
    • 4.2.1 Cold Chain Transport
    • 4.2.2 Non-Cold Chain Transport
  • 4.3 By Application
    • 4.3.1 Biopharma
    • 4.3.2 Chemical Pharma
    • 4.3.3 Specialized Pharma
  • 4.4 By Mode of Transport
    • 4.4.1 Air Shipping
    • 4.4.2 Rail Shipping
    • 4.4.3 Road Shipping
    • 4.4.4 Sea Shipping
  • 4.5 Geography
    • 4.5.1 North America
      • 4.5.1.1 United States
      • 4.5.1.2 Canada
    • 4.5.2 Europe
      • 4.5.2.1 United Kingdom
      • 4.5.2.2 Germany
      • 4.5.2.3 France
      • 4.5.2.4 Italy
      • 4.5.2.5 Rest of Europe
    • 4.5.3 Asia-Pacific
      • 4.5.3.1 China
      • 4.5.3.2 India
      • 4.5.3.3 Japan
      • 4.5.3.4 South Korea
      • 4.5.3.5 Rest of Asia-Pacific
    • 4.5.4 Latin America
      • 4.5.4.1 Brazil
      • 4.5.4.2 Argentina
      • 4.5.4.3 Rest of Latin America
    • 4.5.5 Rest of the World

5 COMPETITIVE LANDSCAPE

  • 5.1 Overview (Market Concentration and Major Players)
  • 5.2 Company Profiles
    • 5.2.1 Deutsche Post DHL
    • 5.2.2 Kuehne + Nagel
    • 5.2.3 UPS (Marken)
    • 5.2.4 DB Group
    • 5.2.5 FedEx
    • 5.2.6 Nippon Express
    • 5.2.7 World Courier
    • 5.2.8 SF Express
    • 5.2.9 CEVA Logistics
    • 5.2.10 Agility
    • 5.2.11 DSV
    • 5.2.12 Kerry Logistics
    • 5.2.13 C.H. Robinson
    • 5.2.14 Air Canada Cargo
    • 5.2.15 Lineage Logistics
    • 5.2.16 United States Cold Storage
    • 5.2.17 Americold Logistics LLC
    • 5.2.18 Nichirei Logistics Group Inc.
    • 5.2.19 Kloosterboer
    • 5.2.20 NewCold Advanced Cold Logistics
    • 5.2.21 VersaCold Logistics Services
    • 5.2.22 Cloverleaf Cold Storage Co.*
  • 5.3 Other Companies

6 FUTURE OF THE MARKET

7 APPENDIX

8 DISCLAIMER